A 15-year-old girl presented with cervical lymphadenopathy and petechiae in the upper extremities. She was treated with antibiotics to no avail.


Acute Myeloid Leukemia Cervical Lymphadenopathy Acute Myeloblastic Leukemia Myeloid Sarcoma AML1 Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Arder DA, Brunning RD, Le Beau MM, et al. Acute myeloid leukemia with recurrent genetic abnormalities. In Swerdlow SH, Harris NL, Campo E, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. Lyon, France, IARC Press, 2008, 110–111.Google Scholar
  2. 2.
    Peterson LF, Zhang DE. The 8;21 translocation in leukemogenesis. Oncogene 2004;23:4255–4262.CrossRefPubMedGoogle Scholar
  3. 3.
    Nucifora G, Dickstein JI, Torbenson V, et al. Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). 1994;8:1533–1538.Google Scholar
  4. 4.
    Andrieu V, Radford-Weiss I, Troussard X, et al. Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype. Br J Heamatol 1996;92:855–865.CrossRefGoogle Scholar
  5. 5.
    Tiacci E, Pileri S, Orieth A, et al. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia. Cancer Res 2004;64:7399–7404.CrossRefPubMedGoogle Scholar
  6. 6.
    Wang XY, Zhou GB, Yin T, et al. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: Implication in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad Sci USA. 2005;102:1104–1109.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Personalised recommendations